Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ott

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
BMC Research Notes|September 20, 2012
The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia--a historical cohort studyPeter Jepsen, Peter Ott, Per Kragh Andersen, et al.
Metabolic Brain Disease|January 15, 2013
Branched-chain amino acids and muscle ammonia detoxification in cirrhosisGitte Dam, Peter Ott, Niels Kristian Aagaard, et al.
Journal of Hepatology|April 15, 2023
Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatmentsPeter Lykke Eriksen, Lars Djernes, Hendrik Vilstrup, et al.
Brain Sciences|November 14, 2020
Memory Traces Formed in Utero-Newborns' Autonomic and Neuronal Responses to Prenatal Stimuli and the Maternal VoiceAdelheid Lang, Peter Ott, Renata Del Giudice, et al.
Ugeskrift for Laeger|August 7, 2014
[Cirrhosis of the liver]Flemming Bendtsen, Fin Stolze Larsen, Peter Ott, et al.
Clinical Pharmacology and Therapeutics|April 17, 2002
The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosageFrank Vinholt Schiødt, Peter Ott, Erik Christensen, et al.
Scandinavian Journal of Gastroenterology|May 20, 2011
Validation of prognostic scores for clinical use in patients with alcoholic hepatitisThomas Damgaard Sandahl, Peter Jepsen, Peter Ott, et al.
American Journal of Medical Genetics. Part A|October 14, 2005
Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestationsLisbeth Birk Møller, Peter Ott, Connie Lund, et al.
Ugeskrift for Laeger|December 14, 2006
[Surgical risk for patients with liver disease]Peter Jepsen, Henrik Toft Sørensen, Hendrik Vilstrup, et al.
Metabolic Brain Disease|November 20, 2024
Blood ammonia concentration measurement - effects of sampling site and cirrhosis during induced hyperammonaemiaLars Djernes, Hendrik Vilstrup, Peter Ott, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
BMC Research Notes|September 20, 2012
The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia--a historical cohort studyPeter Jepsen, Peter Ott, Per Kragh Andersen, et al.
Metabolic Brain Disease|January 15, 2013
Branched-chain amino acids and muscle ammonia detoxification in cirrhosisGitte Dam, Peter Ott, Niels Kristian Aagaard, et al.
Journal of Hepatology|April 15, 2023
Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatmentsPeter Lykke Eriksen, Lars Djernes, Hendrik Vilstrup, et al.
Brain Sciences|November 14, 2020
Memory Traces Formed in Utero-Newborns' Autonomic and Neuronal Responses to Prenatal Stimuli and the Maternal VoiceAdelheid Lang, Peter Ott, Renata Del Giudice, et al.
Ugeskrift for Laeger|August 7, 2014
[Cirrhosis of the liver]Flemming Bendtsen, Fin Stolze Larsen, Peter Ott, et al.
Clinical Pharmacology and Therapeutics|April 17, 2002
The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosageFrank Vinholt Schiødt, Peter Ott, Erik Christensen, et al.
Scandinavian Journal of Gastroenterology|May 20, 2011
Validation of prognostic scores for clinical use in patients with alcoholic hepatitisThomas Damgaard Sandahl, Peter Jepsen, Peter Ott, et al.
American Journal of Medical Genetics. Part A|October 14, 2005
Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestationsLisbeth Birk Møller, Peter Ott, Connie Lund, et al.
Ugeskrift for Laeger|December 14, 2006
[Surgical risk for patients with liver disease]Peter Jepsen, Henrik Toft Sørensen, Hendrik Vilstrup, et al.
Metabolic Brain Disease|November 20, 2024
Blood ammonia concentration measurement - effects of sampling site and cirrhosis during induced hyperammonaemiaLars Djernes, Hendrik Vilstrup, Peter Ott, et al.
Pageof 16